The Hungarian Centre of Excellence for Molecular Medicine (HCEMM) is a game changer organization which catalyzes reforming changes in the research culture and makes an impact in the regional development of Hungarian knowledge regions. HCEMM was created by the union of excellent Hungarian Research Institutions: the University of Szeged, the Semmelweis University and the Biological Research Center of the Hungarian Academy of Sciences. They were joined by the National Research, Innovation and Development Office representing the Hungarian Government as project coordinator and by the European Molecular Biology Laboratory (EMBL) as an advanced scientific partner. HCEMM is financially supported by the EU Program “H2020-EU.4.a. Teaming of excellent research institutions and low performing RDI regions” under the contract number No. 739593, and co-financed by the Hungarian Government and the Partnering Institutions. Notably, HCEMM is also part of the EMBL partnership program.
Research Strategy of HCEMM
HCEMM focuses on and supports molecular medicine-oriented research activities targeting key, highly prevalent ageing-related non-communicable diseases. The research strategy is based on three thematic pillars (Inflammatory and immune diseases; Cardiovascular and metabolic disease; Cancer and genomic instability) and three cross-cutting horizontal themes (Disease in a dish; Precision medicine and preventions; Units of translational research). Further, high-quality excellent research is most efficiently supported by a matrix of advanced core facilities in the HCEMM. Importantly, the thematic pillars and cross-cutting horizontal themes are highly complementary and synergistic in terms of the underlying concepts, research approaches, and the needs for high-end technologies and core facilities.
Advanced Core Facilities at HCEMM
High-quality molecular medicine-oriented research activities at the Hungarian Center of Excellence for Molecular Medicine (HCEMM) are supported by a matrix of advanced core facilities (ACFs). In the premises of the Hungarian Partnering Institutions, three ACFs are currently being set-up:
- Cellular Immunology ACF (University of Szeged)
- In vivo Imaging ACF (Semmelweis University, Budapest)
Single-Cell Omics ACF (Biological Research Center, Szeged)
The Project Steering Committee of the HCEMM project hereby announces a Call for excellent, professional “Heads of Advanced Core Facilities”.
We are searching for Heads for each of the above ACFs who operate, manage, supervise, and develop the respective HCEMM AFC. We seek dynamic and interactive individuals with an excellent professional track record and demonstrated experience and interest in organizing and spearheading the ACF.
HCEMM is an inclusive, equal opportunity employer offering attractive working conditions and benefits appropriate to an international research organization. Female candidates are strongly encouraged to apply.
An initial contract of 5 years will be offered to the successful candidates; this is foreseen to be extended to a maximum of 9 years, subject to an external, independent, international review. Successful candidates will receive an attractive remuneration package and an opportunity to recruit two technicians for each ACF. Importantly, the selected ACF Heads will be constantly helped and trained by heads and managers of the state-of-the-art system of Core Facilities at EMBL.
Please visit https://www.hcemm.eu for more details related to each position (highlights, credentials, qualifications, requirements, and responsibilities). Applicants should submit a cover letter, a CV, a detailed presentation of the professional experience, and a concise description of research interest and plans, all edited as a single PDF file, to email@example.com by 15th April. Please also arrange for 3 letters of recommendation to be also emailed to firstname.lastname@example.org by the same deadline.
For any further details, please contact Tamás Bíró, Director General of HCEMM at email@example.com.